NYSE:XAN - Exantas Capital Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$10.81 -0.10 (-0.92 %)
(As of 11/14/2018 01:08 PM ET)
Previous Close$10.91
Today's Range$10.78 - $10.95
52-Week Range$8.51 - $12.09
Volume1,386 shs
Average Volume150,259 shs
Market Capitalization$345.10 million
P/E Ratio-12.59
Dividend Yield5.50%
Beta0.73
Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial mortgage loans and commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, such as first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, and commercial mortgage-backed securities. The company is also involved in the investment of commercial finance assets, including asset-backed securities, debt tranches of collateralized debt and loan obligations, structured note investments, syndicated corporate loans, and preferred equity investment in a commercial leasing enterprise. It qualifies as a real estate investment trust (REIT) for federal income tax purposes. The company generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York.

Receive XAN News and Ratings via Email

Sign-up to receive the latest news and ratings for XAN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNYSE:XAN
Previous Symbol
CUSIPN/A
Phone212-621-3210

Debt

Debt-to-Equity Ratio2.54
Current Ratio90.57
Quick Ratio90.57

Price-To-Earnings

Trailing P/E Ratio-12.59
Forward P/E Ratio17.44
P/E GrowthN/A

Sales & Book Value

Annual Sales$43.71 million
Price / Sales7.83
Cash FlowN/A
Price / CashN/A
Book Value$17.70 per share
Price / Book0.61

Profitability

EPS (Most Recent Fiscal Year)($0.86)
Net Income$33.53 million
Net Margins29.89%
Return on Equity0.55%
Return on Assets0.17%

Miscellaneous

EmployeesN/A
Outstanding Shares31,660,000
Market Cap$345.10 million
OptionableOptionable

Exantas Capital (NYSE:XAN) Frequently Asked Questions

What is Exantas Capital's stock symbol?

Exantas Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "XAN."

How often does Exantas Capital pay dividends? What is the dividend yield for Exantas Capital?

Exantas Capital announced a quarterly dividend on Friday, September 14th. Stockholders of record on Friday, September 28th will be paid a dividend of $0.15 per share on Friday, October 26th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 5.55%. The ex-dividend date is Thursday, September 27th. This is a boost from Exantas Capital's previous quarterly dividend of $0.10. View Exantas Capital's Dividend History.

How were Exantas Capital's earnings last quarter?

Exantas Capital Corp (NYSE:XAN) released its earnings results on Tuesday, October, 30th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.04. The business had revenue of $14.51 million for the quarter, compared to analyst estimates of $14.60 million. Exantas Capital had a return on equity of 0.55% and a net margin of 29.89%. View Exantas Capital's Earnings History.

When is Exantas Capital's next earnings date?

Exantas Capital is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Exantas Capital.

What price target have analysts set for XAN?

3 brokerages have issued 1 year target prices for Exantas Capital's stock. Their forecasts range from $12.00 to $13.00. On average, they anticipate Exantas Capital's stock price to reach $12.50 in the next year. This suggests a possible upside of 15.6% from the stock's current price. View Analyst Price Targets for Exantas Capital.

What is the consensus analysts' recommendation for Exantas Capital?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exantas Capital in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Exantas Capital.

Has Exantas Capital been receiving favorable news coverage?

News headlines about XAN stock have been trending somewhat positive on Wednesday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Exantas Capital earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an impact on the stock's share price in the near future.

Who are some of Exantas Capital's key competitors?

Who are Exantas Capital's key executives?

Exantas Capital's management team includes the folowing people:
  • Mr. Robert C. Lieber, Chief Exec. Officer (Age 64)
  • Mr. David J. Bryant, Sr. VP, CFO & Treasurer (Age 60)
  • Mr. Thomas C. Elliott, Exec. VP of Fin. & Operations (Age 45)
  • Mr. Eldron C. Blackwell, VP & Chief Accounting Officer (Age 39)
  • Mr. David E. Bloom J.D., Sr. VP - Real Estate Investments (Age 53)

Who are Exantas Capital's major shareholders?

Exantas Capital's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.72%), Acadian Asset Management LLC (3.05%), Forward Management LLC (2.56%), Ancora Advisors LLC (2.03%), Renaissance Technologies LLC (1.35%) and Prudential Financial Inc. (1.09%). View Institutional Ownership Trends for Exantas Capital.

Which major investors are selling Exantas Capital stock?

XAN stock was sold by a variety of institutional investors in the last quarter, including Forward Management LLC, Beach Point Capital Management LP and Citadel Advisors LLC. View Insider Buying and Selling for Exantas Capital.

Which major investors are buying Exantas Capital stock?

XAN stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, BlackRock Inc., MERIAN GLOBAL INVESTORS UK Ltd, Credit Suisse AG, Renaissance Technologies LLC, Martingale Asset Management L P, Prudential Financial Inc. and Russell Investments Group Ltd.. View Insider Buying and Selling for Exantas Capital.

How do I buy shares of Exantas Capital?

Shares of XAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exantas Capital's stock price today?

One share of XAN stock can currently be purchased for approximately $10.81.

How big of a company is Exantas Capital?

Exantas Capital has a market capitalization of $345.10 million and generates $43.71 million in revenue each year. The company earns $33.53 million in net income (profit) each year or ($0.86) on an earnings per share basis.

What is Exantas Capital's official website?

The official website for Exantas Capital is http://www.exantas.com.

How can I contact Exantas Capital?

Exantas Capital's mailing address is 717 FIFTH AVENUE, NEW YORK NY, 10022. The company can be reached via phone at 212-621-3210 or via email at [email protected]


MarketBeat Community Rating for Exantas Capital (NYSE XAN)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  10 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about Exantas Capital and other stocks. Vote "Outperform" if you believe XAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel